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Rapid inference of antibiotic resistance and
susceptibility by genomic neighbour typing
Karel Břinda 1,2*, Alanna Callendrello1, Kevin C. Ma3, Derek R. MacFadden1,4,
Themoula Charalampous 5, Robyn S. Lee1,6, Lauren Cowley7, Crista B. Wadsworth8,
Yonatan H. Grad 3, Gregory Kucherov 9,10, Justin O’Grady 11,5, Michael Baym 2 and
William P. Hanage 1
Surveillance of drug-resistant bacteria is essential for healthcare providers to deliver effective empirical antibiotic therapy.
However, traditional molecular epidemiology does not typically occur on a timescale that could affect patient treatment and
outcomes. Here, we present a method called ‘genomic neighbour typing’ for inferring the phenotype of a bacterial sample by
identifying its closest relatives in a database of genomes with metadata. We show that this technique can infer antibiotic susceptibility and resistance for both Streptococcus pneumoniae and Neisseria gonorrhoeae. We implemented this with rapid k-mer
matching, which, when used on Oxford Nanopore MinION data, can run in real time. This resulted in the determination of
resistance within 10 min (91% sensitivity and 100% specificity for S. pneumoniae and 81% sensitivity and 100% specificity
for N. gonorrhoeae from isolates with a representative database) of starting sequencing, and within 4 h of sample collection
(75% sensitivity and 100% specificity for S. pneumoniae) for clinical metagenomic sputum samples. This flexible approach has
wide application for pathogen surveillance and may be used to greatly accelerate appropriate empirical antibiotic treatment.

I

nfections pose multiple challenges to healthcare systems and
contribute to higher mortality, morbidity and escalating cost.
Clinicians must regularly make rapid decisions on empirical antibiotic treatment of infectious syndromes without knowing the causative pathogen (or pathogens) or whether they are
drug-susceptible or drug-resistant. In some cases, this is directly
linked to poor outcomes; in the case of septic shock, the risk of
death increases by an estimated 10% with every 60 min of delay in
initiating effective treatment1.
The molecular epidemiology of infectious disease allows us to
identify high-risk pathogens and to determine their patterns of
spread on the basis of their genetics or (increasingly) genomics.
Conventionally, such studies, including outbreak investigations and
characterization of previously untested resistant strains, have been
conducted in retrospect, but this has been changing with the availability of increasingly inexpensive sequencing technologies2,3. The
wealth of data generated by genomics are promising, but introduces
a challenge because while many features of a sequence are correlated
with the phenotype of interest, few are causative.
Prescription, however, has long been informed by correlative
features when causative ones are difficult to measure; for example,
whether the same syndrome or pathogen occurring in other patients
from the same clinical environment have responded to a particular
antibiotic. This has also been observed at the genetic level as a result
of genetic linkage between resistance elements and the rest of the
genome. An example is given by the pneumococcus S. pneumoniae.
The Centers for Disease Control and Prevention (CDC) has rated

the threat level of drug-resistant pneumococcus as “serious”4. While
resistance arises in pneumococci through a variety of mechanisms,
approximately 90% of the variance in the minimal inhibitory concentration (MIC) for antibiotics of different classes can be explained
by the loci determining the strain type5, even though none of these
loci themselves causes resistance. Thus, in the overwhelming majority of cases, resistance and susceptibility can be inferred from coarse
strain typing based on the population structure. This population
structure could be leveraged to offer an alternative approach to
detecting resistance whereby rather than detecting high-risk genes,
we identify high-risk strains. While many approaches have been
developed to identify whether a pathogen carries mutations or
genes known to confer resistance6–21 (see ref. 22 for a comprehensive
review), this is not equivalent to the clinical question of whether the
pathogen is susceptible.
We present a method called genomic neighbour typing that
can bring molecular epidemiology closer to the bedside and provide information relevant to treatment at a much earlier stage. Our
method takes sequences generated from a sample in real time and
matches them to a database of genomes to identify the closest relatives. Because closely related isolates usually have similar properties, this yields an informed heuristic regarding the phenotype of
the pathogen. We demonstrate this by identifying drug-resistant
and drug-susceptible clones for both S. pneumoniae (the pneumococcus) and N. gonorrhoeae (the gonococcus) within minutes
after the start of sequencing using Oxford Nanopore Technology
(ONT). The method has many potential applications depending on
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the specific pathogen and the quality of the databases available for
matching, which we discuss together with its limitations.

Results

Resistance is associated with clones in S. pneumoniae and
N. gonorrhoeae. To quantify the association of clones with antibiotic resistance of the pathogens S. pneumoniae and N. gonorrhoeae,
we constructed optimal predictors of resistance from bacterial lineages and measured the associated area under the receiver operating
characteristic curve (AUC) (Supplementary Fig. 1). First, we applied
the method to 616 pneumococcal genomes from a carriage study
of children in Massachusetts, USA23,24. Second, we used 1,102 clinical gonococcal isolates collected from 2000 to 2013 by the CDC’s
Gonococcal Isolate Surveillance Project25. In both cases, the datasets comprised draft genome assemblies from Illumina HiSeq reads,
resistance data and lineages inferred from sequence clusters computed using Bayesian analysis of population structure26. Lineages
of S. pneumoniae were predictive for benzylpenicillin, ceftriaxone,
trimethoprim–sulfamethoxazole, erythromycin and tetracycline
resistance, with AUC values ranging from 0.90 to 0.97 (Supplementary
Fig. 2), which is consistent with previous works5. For N. gonorrhoeae,
ciprofloxacin, ceftriaxone and cefixime attained comparably large
AUC values (from 0.93 to 0.98), whereas azithromycin demonstrated a lower association (AUC value of 0.80) (Supplementary
Fig. 3), which is as previously observed25.
Rapid identification of nearest known relatives from sequencing reads. Based on the observed associations, we developed an
approach that we term genomic neighbour typing to predict the
phenotype from sequencing data. Genomic neighbour typing is a
two-step algorithm that first compares a provided sample to a database of reference genomes with a known phylogeny and phenotype,
and then predicts the probable phenotype of the sample based on
the best hits (nearest neighbours) and their matching quality. We
apply this here to the detection of drug resistance.
To implement genomic neighbour typing, we developed software
called resistance-associated sequence elements (RASE) (Fig. 1).
RASE takes a stream of nanopore reads and compares their k-mer
content to references using a modified version of ProPhyle27,28,
which is a metagenomic classifier that implements a fast and memory-efficient exact coloured de Bruijn graph data structure29 using
a Burrows–Wheeler transform (BWT) index30 (Methods). Using
ProPhyle RASE identifies which references are the most similar
to the read and increases their similarity weights (this approach
was inspired by but differs from other similar approaches such as
Kraken31 and Kallisto32). These weights are cumulative scores that
capture sample-to-reference similarity; they are set to zero at the
beginning and are increased on the fly as sequencing proceeds
according to the ‘information content’ of each read (Methods).
Generally speaking, longer reads, such as those covering multiple
accessory genes, tend to be specific and have high scores, whereas
short reads or reads from the core genome are found in many lineages, tend to be nonspecific and have low scores. Weights serve as
a proxy to the inverted genetic distance between the sample and
the references.
Resistance or susceptibility is predicted in two steps based on
the computed weights, the population structure and the reference
phenotypes. First, RASE identifies the lineage of the best-matching
reference genome and estimates the confidence of lineage assignment by comparing the two best-matching lineages to compute a
‘lineage score’ (Methods). Subsequently, RASE identifies the best
match within that lineage and predicts resistance from the nearest resistant and susceptible neighbours. A comparison of their
weights provides a ‘susceptibility score’, which quantifies the risk of
resistance (Methods). When the weights are too similar, the confidence of the call is considered low; this happens when resistant and
456

susceptible strains are insufficiently genetically distinct, which is
often the case for resistance that has recently emerged in evolutionary history (Methods). The ability to pinpoint the closest relatives
in the database offers further resolution, even in the case where the
resistance phenotype varies within a lineage.
Results of RASE are reported in real time as the best match in the
database, together with susceptibility scores to the antibiotics being
tested and a proportion of matching k-mers for quality control. As
the run progresses, the scores fluctuate and eventually stabilize (an
example is shown in Fig. 2).
RASE databases for hundreds of S. pneumoniae and N. gonorrhoeae
strains. We constructed RASE databases for S. pneumoniae and
N. gonorrhoeae from the same data as described above (Methods).
We assigned each pneumococcal and gonococcal strains to antibiotic-specific resistance categories using the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) breakpoints33
and the CDC Gonococcal Isolate Surveillance Project (GISP)
breakpoints34, respectively (Methods). Where MIC data were
unavailable or insufficiently specific, we estimated the probable
resistance phenotype using ancestral state reconstruction (Methods;
Supplementary Note 1; Extended Data Figs. 3 and 4). To verify the
results, we tested eight pneumococcal isolates for which resistance
phenotypes were not originally available (Methods), and the measured MICs by microdilution matched the expected phenotypes
(shown in bold in Table 1). We constructed the ProPhyle k-mer
indexes using a k-mer length that was optimized to minimize prediction delays (k = 18; Methods). The obtained pneumococcal and
gonococcal RASE databases occupy 321 MB and 242 MB of RAM
(×4.3 and ×12, respectively, compression rate) and can be further
compressed for transmission to 47 MB and 32 MB (×29 and ×90,
respectively, compression rate), respectively (Extended Data Fig. 1).
This would allow RASE to be used on portable devices and its databases to be easily transmitted to the point of care over links with a
limited bandwidth.
RASE identifies strains in the database within minutes. We
first examined two pneumococcal isolates that were used to build
the RASE database (100% sensitivity and 100% specificity, n = 10;
Table 1a) to test whether RASE can function in ideal circumstances.
In the case of a fully susceptible isolate (SP01), the correct lineage and sequenced strain were identified within 1 min and 7 min,
respectively. A multidrug-resistant isolate (SP02) was predicted
even faster, with both lineage and the sequenced strain correctly
detected and stabilized within 1 min. To compare our method to
gene-based approaches for detecting resistance22, we evaluated how
long it took for resistance genes to be sequenced on the device. We
observed that at least 25 min would be needed for single copies to be
detected (Supplementary Note 2; Extended Data Fig. 2).
We then performed a similar evaluation with five gonococcal isolates from the database (57% sensitivity and 100% specificity, n = 20;
Table 2a); however, here, we selected more complicated cases. First,
we tested a susceptible isolate (GC01), for which RASE identified
the correct strain and antibiogram within 3 min of sequencing. We
then sequenced an isolate (GC02) with an uncommon mechanism
of cephalosporin resistance that has recently emerged35. Under
such circumstances, the resistant strain and its susceptible neighbours tend to be genetically very similar, which could confound
our analysis. However, RASE was still able to identify the correct
resistance phenotypes in 9 min, with the delay due to the difficulty
in distinguishing between the close relatives, which was reflected
by a susceptibility score in the low-confidence range (Methods).
This was repeated in further experiments with the same isolate
(GC03), which consistently reported low confidence in the resistance phenotype (Methods). This feature of our approach intends
to alert the operators to indicate that further testing is necessary.
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Fig. 1 | Overview of the RASE approach. In the first loading step, the precomputed RASE database is loaded into memory. As reads are generated, they are
matched against the database using ProPhyle to calculate similarity to individual strains. The weights for the most similar strains (D and E in the figure) are
increased proportionately to the number of matching k-mers. Finally, resistance is predicted from the obtained weights and from the resistance profiles of
the database strains in the following manner. First, the best lineage is identified as the lineage of the best match (having the highest weight, E in the figure)
and its score is calculated (lineage score (LS)). Second, for every antibiotic, a score quantifying the chance of susceptibility (susceptibility score (SS)) is
calculated based on the most similar susceptible and resistant strains inside the identified lineage (B and E in the figure, respectively). The susceptibility or
resistance to each of the antibiotics is predicted from their susceptibility scores by a comparison with a threshold (0.5 in the default setting) and reported
together with the lineage, the best matching strain and the known properties of that strain (for example, the original antibiograms and the MLST-identified
sequence type or serotype).

In this experiment, RASE also resolved sample mislabelling
(Supplementary Note 3). For a multidrug-resistant isolate (GC04),
RASE predictions stabilized within 2 min, but incorrectly predicted
susceptibility to ceftriaxone. A subsequent analysis revealed that the
ceftriaxone MIC of the sample was equal to the CDC GISP breakpoint (0.125 μg ml–1), whereas the best match in the database had an
MIC of 0.062 μg ml–1, within a single doubling dilution. We further
found that RASE performed well even with extremely poor data
and low-quality reads (for example, GC05; Supplementary Note 4).
We also evaluated how genomic neighbour typing would perform
if RASE used Kraken31 instead of ProPhyle27,28, and results are presented in Supplementary Note 5.
RASE identifies the closest relative of previously untested
isolates. We next examined four pneumococcal isolates (89% sensitivity and 100% specificity, n = 20; Table 1b) for which the serotype
and limited antibiogram and lineage data were known. We compared the following three characteristics of the sample to assess our
performance: the serotype, the sequence type as determined by multilocus sequence typing (MLST) and the antibiograms (benzylpenicillin, ceftriaxone, trimethoprim–sulfamethoxazole, erythromycin
and tetracycline resistance according to the EUCAST breakpoints33).
In all cases, the closest relative was identified within 5 min, even
if the correct MLST sequence type was absent from the RASE database (an example is shown in Fig. 2). The two samples from the 23F
clone (SP03 and SP06) were correctly called as being closely related
to the Tennessee 23F-4 clone identified by the Pneumococcal

Molecular Epidemiology Network, a clone strongly associated with
macrolide resistance36. Consistent with this, the two samples were
indeed resistant to erythromycin. However, the Tennessee 23F-4
clone was absent from the Massachusetts sample, with the best
match being a comparatively distantly related strain that was resistant to penicillin, but susceptible to erythromycin. This illustrates
the importance of a relevant database.
We evaluated RASE with 14 clinical gonococcal isolates from the
RaDAR-Go project37 (Switzerland, 2015–2016) (93% sensitivity and
100% specificity, n = 56; Table 2b). These isolates were previously
sequenced using nanopore and have full antibiograms available38.
The 55 out of 56 correct calls indicate the strength of the genomic
neighbour typing in a clinical setting. The only incorrect call (susceptibility to azithromycin for GC15) was marked as being low confidence on the basis of a poor susceptibility score. It should be noted
that the ranges for what is considered low confidence could vary
among settings and pathogens, but can be empirically determined
and modified by users. In this case, our results suggest that informative results can be obtained even when using a database from one
region (the United States) to predict phenotypes in another region
(Europe). However, this may not be the case for all pathogens.
Inference is still informative but lower quality on highly divergent lineages. As noted above, an important precondition of
genomic neighbour typing is a comprehensive and relevant reference database. To evaluate the performance of RASE in a setting with an incomplete database, we used the gonococcal WHO
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(Non-susc.) calls, respectively. The dashed lines mark selected time points (1 min, 5 min and the end of sequencing (2,700 min)). b–d, Similarity rank
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Table 1 | Predicted phenotypes of S. pneumoniae for database isolates (a), non-database isolates (b) and metagenomes (c)
(a) Database isolates
Matched
Lineage
confidently k-mers
(%)
detected

Serotype
Actual

SP01

Yes

16

SP02

Yes

9.6

Sample

Antibiogram
CRO

Antibiogram
ERY

Antibiogram
PEN

Antibiogram
SXT

Antibiogram
TET

MLST CC
match match

Best
match

Actual

Best
match

Actual Best
Actual
match

Best
Actual Best
Actual Best
match
match
match

11D

11Da

S

Sa

S

Sa

S

Sa

S

Sa

S(1)

S(1)a

Yesa

Yesa

19A

19Aa

R

Ra

R

Ra

R

Ra

R

Ra

R(2)

R(2)a

Yesa

Yesa

(b) Non-database isolates
Matched Serotype
Lineage
confidently k-mers
(%)
detected
Actual
Best
match

Antibiogram
CRO

Antibiogram
ERY

Actual Best
match

Actual

Best
Actual
match

Best
Actual Best
Actual Best
match
match
match

SP03

Yes

3.1

23F

23Fa

R

Ra

R

S(3)b

R

Ra

R

Ra

S

Sa

OoDc

Yesa

SP04

Yes

12

19A

19A

R

a

R

R

a

R

R

R

a

R

a

R

R

R

c

OoD

Yesa

SP05

No

1.8

19F

19Fa

R

Ra

R

Ra,d

R

Ra

R

Ra,d

R

Ra,d

OoDc

Yesa

SP06

Yes

8.3

23F

23F

R

R

R

S

R

R

R

R

S

S

OoD

Yesa

Sample

a

a

a

Antibiogram
PEN

(3)b

Antibiogram
SXT

a

a

Antibiogram
TET

(4)a

a

MLST CC
match match

c

(c) Metagenomes
Lineage
confidently
detected

SP (%)

Matched
Antibiogram ERY
k-mers (%)
Actual
Best match

Antibiogram PEN

Antibiogram TET

Actual

Best match

Actual

Best match

SP07

No

2.3

0.2

NA

Sc

S

Sa

R

S(5)b

No

2.5

0.9

S

a

SP08

S

S

S

S

S(6)a

SP09

No

4.0

1.2

NA

Sc

S

Sa

S

S(7)a

SP10

Yes

21

5.2

R

R

R

R

R

R(8)a

SP11

Yes

70

14

R

a

R

R

a

R

R

R(8)a

SP12

Yes

86

17

S

Sa

S

Sa

R

S(5)b

Sample

a

a,d

a

The table displays actual and predicted resistance phenotypes (where ‘S’ represents susceptible and ‘R’ represents non-susceptible) for individual experiments and information on the match of the
predicted MLST-identified sequence type and the clonal complex (CC). Resistance categories in bold were inferred using ancestral reconstruction and were confirmed using phenotypic testing
(see Methods and Supplementary Table 2). Metagenomic samples were sorted by the estimated fraction of S. pneumoniae reads (SP). aCorrect prediction. bIncorrect prediction. cCannot be evaluated.
d
Low confidence call. OoD, out of database; (n), identity of a retested sample; NA, not available. For definitions of antibiotics see Fig. 2.

(World Health Organization) 2016 reference strain collection39.
This includes a global collection of 14 diverse isolates from Europe,
Asia, North America and Australia, collected over two decades and
exhibiting phenotypes ranging from pan-susceptibility to multidrug resistance, and as such, the GISP database is expected to be
non-representative in this study. The WHO strains are available
from the National Collection of Type Cultures, and were previously
sequenced using nanopore38 and genetically and phenotypically
characterized39. Surprisingly, RASE correctly identified all MLSTidentified sequence types represented in the database, and in seven
cases it provided fully correct resistance phenotypes (67% sensitivity and 91% specificity, n = 56; Supplementary Table 1). In six out
of seven cases where the complete resistance profile was not recovered, the closest relatives were correctly identified, but were genetically divergent from the query isolates (Supplementary Note 6). In
one case, the errors were due to a misidentification of the closest
relatives by ProPhyle. Therefore, most prediction errors could be
addressed with a more comprehensive database.
RASE can identify resistance in pneumococcus from sputum
metagenomic samples. Because bacterial culture and phenotyping via agar-dilution, Etest or disk diffusion introduces significant
delays in resistance profiling, direct metagenomic sequencing of
clinical samples would be preferable for point-of-care use. We therefore analysed metagenomic nanopore data from sputum samples
obtained from patients suffering from lower respiratory tract infections40 (UK, 2017), selecting six samples from the study that were

already known to contain S. pneumoniae (75% sensitivity and 100%
specificity, n = 16; Table 1c).
One sample (SP10) contained DNA from multiple bacterial species. However, within 5 min, the sequence was identified to belong
to the Swedish 15A-25 clone (ST63), which is also known to be
associated with resistance phenotypes including macrolides and
tetracyclines41. This sample was confirmed to be resistant to erythromycin and to clindamycin, tetracycline and oxacillin according
to the EUCAST breakpoints33. The original report of the Swedish
15A-25 clone did not report resistance to penicillin antibiotics41,
which has subsequently emerged in this lineage. However, our
database correctly identified the risk of penicillin resistance in this
sample. The metagenomes SP11 and SP12 contained an estimated
>20% reads that matched S. pneumoniae, and their serotypes were
identified to be 15A and 153, respectively. The susceptibility scores
of the best matches were fully consistent with the resistance profiles
found in the samples, with the exception of tetracycline resistance
in SP12 due to an incomplete database (Supplementary Note 7). The
last remaining samples, SP07–SP09, contained <5% unambiguously
pneumococcal reads. Despite the low proportions, all predicted phenotypes were concordant with phenotypic tests, with the exception
of SP07, which matched the same strain as SP12 (discussed above).

Discussion

This paper presents a method, which we termed genomic neighbour
typing, to pinpoint the closest relatives of a query genome within
a suitable database and then to infer the phenotypic properties
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Table 2 | Predicted phenotypes of N. gonorrhoeae for database isolates (a) and non-database isolates (b)
(a) Database isolates
Sample

Lineage
confidently
detected

Matched
k-mers (%)

Antibiogram AZM

Antibiogram CFM

Antibiogram CIP

Antibiogram CRO

GC01

Yes

GC02

Actual

Best
match

Actual

Best
match

Actual

Best
match

Actual

Best
match

27

S

Sa

S

Sa

S

Sa

S

Sa

Yesa

Yes

27

S

S

a

R

R

a,c

S

S

a

R

R

a,c

Yesa

GC03

Yes

33

S

S

a

R

S

b,c

S

S

a

R

S

b,c

Yesa

GC04

Yes

21

S

Sa

R

Ra

R

Ra

R

Sb

Yesa

GC05

Yes

7

R

R

S

S

S

S

S

S

Yesa

a

a

a

a

MLST
match

(b) Non-database isolates
Sample

Lineage
confidently
detected

Matched
k-mers
(%)

Antibiogram AZM

Antibiogram CFM Antibiogram CIP

Antibiogram
CRO

Actual

Best
match

Actual

Best
match

Actual

Best
match

Actual

Best
match

GC06

Yes

19

S

Sa

R

Ra

R

Ra

S

Sa

GC07

No

20

S

S

a

S

S

a

R

R

a

S

Sa

GC08

No

19

S

S

a

S

S

a

R

R

a

S

Sa

GC09

No

18

S

Sa

S

Sa

S

Sa

S

Sa

GC10

No

20

S

S

a

S

S

a

R

R

a

S

Sa

GC11

No

20

S

S

a

S

S

a

R

R

a

S

Sa

GC12

No

20

S

Sa

S

Sa

R

Ra

S

Sa

GC13

Yes

20

S

S

a

S

S

a

R

R

a

S

Sa

GC14

Yes

19

S

S

a

S

S

a

R

R

a

S

Sa

GC15

Yes

19

R

Sb,c

S

Sa

S

Sa

S

Sa

GC16

No

18

S

S

a

S

S

a,c

R

R

a

S

Sa,c

GC17

No

19

S

S

a

S

S

a,c

R

R

a

S

Sa,c

GC18

No

20

S

Sa

S

Sa

R

Ra

S

Sa

GC19

Yes

18

S

S

S

S

R

R

S

Sa

a

a

a

The table displays actual and predicted resistance phenotypes (S and R) for individual experiments and information on the match of the predicted MLST-identified sequence type. Correct prediction.
b
Incorrect prediction. cLow-confidence call. AZM, azithromycin; CFM, cefixime; CIP, ciprofloxacin.
a

of the query strain on the basis of the reported properties of its
relatives. At present, the precise lineage of a bacterial pathogen is
often determined after most important clinical decisions have been
made. However, incorporating genomic neighbour typing at an earlier stage offers a way of leveraging bacterial population structure
to gain information on resistance and susceptibility, and to guide
antimicrobial therapy. The results from the metagenomic samples
suggest that it is possible to apply this approach directly to clinical
samples, and the success with both S. pneumoniae and N. gonorrhoeae indicates that it may have wide application.
The two pathogens studied here present contrasting features; the
gonococcus is Gram-negative, harbours plasmids and has a strikingly uniform core genome, while the pneumococcus is Grampositive, does not contain plasmids and is diverse in both its core
and accessory genome. Both exhibit high rates of homologous
recombination, which is expected to both spread chromosomally
encoded resistance elements and to scramble the phylogenetic signal that we use to identify the lineages. Despite these differences and
the large degree of recombination, our approach performs well with
both pathogens, with some differences that indicate opportunities
and limitations of the application.
The initial identification of the closest relative was consistently
more robust in the pneumococcus than the gonococcus, which is
a result of the former having more k-mers that are specific to an
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individual lineage, thus reflecting greater sequence diversity. As a
consequence of the much lower diversity in gonococcus, when multiple closely related genomes are present in the database, RASE fluctuated between them, even though it correctly identified the region
of the phylogeny. If these genomes vary in their resistance profile,
this is properly reflected in an uncertain susceptibility score that
indicates caution and further investigation are merited (for example, GC03).
As in all inference, the principle limitation of genomic neighbour typing is the representativeness of the database. While we
have made use of relatively small samples from limited geographical areas to demonstrate proof of principle, in practice, there are
multiple examples of large genomic databases generated by public
health agencies, which could be combined with metadata on resistance for genomic neighbour typing. Such databases could, if necessary, be supplemented with local sampling. The relevant question
for our approach therefore becomes whether the database contains
a sufficiently high proportion of strains that will be encountered
in the clinic and whether the resistance data are correct. Further
work is required to determine the optimal structure and contents
of databases for each application, but we emphasize the range of
pathogens that appear to show promise for this approach. These
include Escherichia coli, in which data on MLST-identified sequence
types supplemented with epidemiological information consistently
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produced AUC values in excess of 0.90 for multiple antibiotics42,
which suggests that there is great potential for neighbour typing
to offer excellent resolution that is superior to MLST. However, we
anticipate that genomic neighbour typing may be less suitable in
cases when there is little within-species genomic variation (meaning it is hard to identify the nearest neighbour) or when resistance
rapidly emerges on independent and diverse genomic backgrounds
(meaning resistance is poorly correlated with those backgrounds)
(Supplementary Note 8).
In cases where the infectious agent is unknown, this problem is
significantly more challenging. k-mers from one pathogen can match
others and produce false predictions, and so the choice of the correct database for prediction is key. Doing this will probably require
a two-step solution in which the reads are first passed through a
metagenomic classifier such as Centrifuge43 or MetaMaps44, which
would be used to select the correct RASE database on which to
make a resistance call.
Another limitation is the time required for sample preparation,
which currently includes human DNA depletion, DNA isolation
and library preparation, thereby taking a total of 4 h. However, this
is a rapidly evolving area of technology and automated rapid library
preparation kits are already in development45. Further advances in
this space, in particular for the preparation of metagenomic samples, will be required to bring the method closer to the bedside.
We have demonstrated that effectively predicting resistance and
susceptibility from sequencing data does not require knowledge
of causal resistance determinants. In fact, neighbour typing only
requires that the phenotype be sufficiently strongly associated with
the population structure to make reliable predictions.
A key advantage of this approach is that it requires very little
genomic data, thus it is not limited by high error rates or low coverage. In particular, it is not attempting to define the exact genome
sequence of the sample being tested, but merely which lineage it
comes from. As a result, even when a small fraction of k-mers in
the read are informative in matching to the RASE database, this is
sufficient to call the lineage. This has the benefit of being faster than
gene detection by virtue of the informative k-mers being distributed
throughout the genome, and so more likely to appear in the first few
reads sequenced by the nanopore. Therefore, the approach we present here can be seen as an application of compressed sensing; that is,
by measuring a sparse signal distributed broadly across our data, we
can identify it with comparatively few error-tolerant measurements.
Genomic neighbour typing can also be used to detect other phenotypes that are sufficiently tightly linked to a phylogeny, such as
virulence. Further applications may include rapid outbreak investigations, as the closely related isolates involved in the outbreak
would all be predicted to match to the same strain in the RASE
database. The approach also lends itself to enhanced surveillance,
including in the field; the 2014–2016 Ebola outbreak in West Africa,
for example, saw MinION devices used in remote locations without
advanced healthcare facilities2. Finally, at present, empirical treatment decisions are made within successive ‘windows’46, in which
increasing information becomes available, from initial Gram stain
to full phenotypic characterization. The information from genomic
neighbour typing is a natural complement to this process and has
the potential to improve therapy long before it would become
clinically apparent that the patient is not responding or before phenotypic susceptibility data were available. The combination of highquality RASE databases with genomic neighbour typing offers an
alternative forward-looking model for diagnostics and surveillance,
with wide applications for the improved clinical management of
infectious disease.

Methods

Overview. RASE uses rapid approximate k-mer-based matching of long sequencing
reads against a database of strains to predict resistance via neighbour typing. The

database contains a highly compressed exact k-mer index, a representation of the
tree population structure and metadata such as lineage, resistance profiles, MLSTbased sequence type and serotype. The RASE prediction pipeline iterates over reads
from the nanopore sequencer and provides real-time predictions of lineage and
resistance or susceptibility (Fig. 1).
Resistance profiles. For all antibiotics, RASE associates individual strains with
a resistance category: ‘susceptible’ (S) or ‘non-susceptible’ (R). First, intervals of
possible MIC values are extracted using regular expressions from the available textual
antibiograms. For instance, ‘≥4’, ‘2’ and ‘NA’ would be translated to the intervals
[4, + ∞), [2, 2] and [0, + ∞), respectively. Then the acquired intervals are compared to
the antibiotic-specific breakpoints. If a given breakpoint is above or below the interval,
susceptibility or non-susceptibility is reported, respectively. However, no category
can be assigned at this step if the breakpoint lies within the extracted interval, an
antibiogram is entirely missing, it is insufficiently specific or its parsing failed. Finally,
missing categories are inferred using ancestral state reconstruction on the associated
phylogenetic tree while maximizing parsimony (that is, minimizing the number
of nodes switching its resistance category; Extended Data Figs. 3 and 4). When the
solution for a node is not unique, non-susceptibility is assigned.
Genomic neighbour typing using nanopore sequencing. All reference strains in
the database are associated with similarity weights that are set to zero at the start
of the run. Each time a new read is read from the stream, k-mer-based matching is
applied to identify the strains with the maximum number of matching k-mers (see
below). Such strains are nearest neighbours to the read in the database according to
the 1/(‘number of matched k-mers’) pseudodistance.
The weights of the nearest neighbours are then increased according to the
information content of the read, calculated as the number of matched k-mers
divided by the number of nearest neighbours. Reads that do not match (that is,
0 matching k-mers in the database) are not used in subsequent analysis. The
computed matches are also used for updating the k-mer score (KS), which is the
proportion of matched k-mers in all reads. The KS helps to assess whether a sample
is truly matching the database and whether predicting resistance for the database
species makes sense.
The obtained weights serve as a proxy to the inverted genetic distance and
are used as a basis for the subsequent predictions of the lineage and the antibiotic
resistance and susceptibility.
Predicting lineage. A lineage is predicted as the lineage of the best-matching
reference strain; that is, the one with the largest weight. The quality of lineage
prediction is further quantified using a lineage score (LS), calculated as LS = 2 f/
(f + t) – 1, where f and t denote the weights of the best matches in the first
(‘predicted’) and in the second best (‘alternative’) lineage, respectively. The values
of the LS can range from 0.0 to 1.0 with the following special cases: LS = 1.0 means
that all reads were perfectly matching the predicted lineage, whereas LS = 0.0
means that the predicted and alternative lineages were matched equally well.
The LS is used to measure how well a sample matches the identified lineage.
If the LS is higher than a specified threshold (0.6 in default settings), the call is
considered successful. If the score is lower than this, the sample cannot be securely
assigned to a lineage, and this should draw the attention of the operators. Note that
custom RASE databases may require a recalibration of the threshold.
Predicting resistance and susceptibility. Resistance or susceptibility is
independently predicted for individual antibiotics based on the weights of
the strains that belong to the predicted lineage. These are used to calculate a
susceptibility score, which is further interpreted by comparing to predefined
thresholds.
The susceptibility score (SS) is calculated as SS = s/(s + r), where s and r denote
the weights of the best-matching susceptible and best-matching non-susceptible
strains within the lineage, respectively. The values of the SS can range from 0.0 to
1.0 with the following special cases: SS = 0.0 and SS = 1.0 mean that all reads match
only resistant or susceptible strains in the lineage, respectively. In practice, this
happens only if the lineage is entirely associated with resistance or susceptibility.
SS = 0.5 means that the best matching resistant and susceptible strains are matched
equally well. As follows from the score definition, if SS is greater than 0.5, then the
best-matching strain is susceptible, otherwise it is non-susceptible.
The SS is used for predicting resistance or susceptibility and for evaluating
the confidence of the prediction. If the SS is greater than 0.5, susceptibility to the
antibiotic is reported, otherwise non-susceptibility is reported. Hence, resistance
is predicted as the resistance of the best match. However, when the SS is within the
[0.4, 0.6] range, it is considered a low-confidence call, and as such it should draw
the attention of the operators; this usually indicates that resistance or susceptibility
has recently emerged in the evolutionary history, and genomic neighbour typing
may not be able to confidently distinguish between these similar, but phenotypically
distinct, strains. Note that the thresholds above might require a further recalibration
based on the specific database, antibiotics and application of RASE.
S. pneumoniae RASE database. The S. pneumoniae RASE database was
constructed using the EUCAST breakpoints33 for the following antibiotics (mg l–1):
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ceftriaxone (0.25), erythromycin (0.25), benzylpenicillin (0.06), trimethoprimsulfamethoxazole (1.00) and tetracycline (1.00). While we used the above values in
the present work, others may be readily defined and the database rapidly updated.
This is especially useful in cases where breakpoints may vary depending on the
site of infection (as is the case with pneumococcal meningitis and otitis media, for
which lower MICs are considered to be resistant33).
The draft assemblies were downloaded from the SRA FTP server using
the accession codes provided in table 1 in ref. 24. The phylogenetic tree was
downloaded from DataDryad (accession no.: https://doi.org/10.5061/dryad.t55gq).
The pneumococcal ProPhyle index was constructed with the k-mer size of k = 18.
The obtained S. pneumoniae RASE database, including the source code and
data, is available at https://github.com/c2-d2/rase-db-spneumoniae-sparc.
N. gonorrhoeae RASE database. The N. gonorrhoeae RASE database was
constructed with the CDC GISP breakpoints34 for the following antibiotics (mg l–1):
azithromycin (2.0), cefixime (0.25), ciprofloxacin (1.0) and ceftriaxone (0.125).
Before applying the breakpoints, azithromycin MICs for strains collected before
2005 were doubled to correct for the known inconsistencies of the phenotyping
protocol, which were due to a change in formulation of the commercial media47.
The draft assemblies and the phylogenetic tree were downloaded from Zenodo
(accession no.: https://doi.org/10.5281/zenodo.2618836). The following three
prevalent types of plasmids48 were downloaded from GenBank, localized in the
GISP database using BLAST49 and removed from the dataset: the cryptic plasmid
pJD1 (GenBank accession no.: NC_001377.1), the beta-lactamase plasmid pJD4
(GenBank accession no.: NC_002098.1) and the conjugative plasmid pEP5289
(GenBank accession no.: GU479466.1). The gonococcal ProPhyle index was
constructed with the k-mer size of k = 18.
The obtained N. gonorrhoeae RASE database, including the source code and
data, is available at https://github.com/c2-d2/rase-db-ngonorrhoeae-gisp.
k-mer-based matching. Reads were matched against the RASE databases using
the ProPhyle classifier27,28 (commit b55e026) and its ProPhex component50,51. The
ProPhyle index stores k-mers of all strains in a highly compressed form, reducing
the required memory footprint. In the database construction phase, the k-mers
of the strains are first propagated along the phylogenetic tree and then greedily
assembled to simplitigs52. The obtained simplitigs are then placed into a single text
file, for which a BWT index is constructed30.
In the course of sequencing, each read is decomposed into overlapping k-mers.
The k-mers are then searched in the BWT index by ProPhex using BWT search
using a sliding window50. For every k-mer, the obtained matches are translated back
on the tree. This provides a list of nodes whose descending leaves are the strains
containing that k-mer. Finally, strains with maximum number of matched k-mers
are identified for each read and reported in the SAM/BAM format53.
Optimizing the k-mer length. The k-mer length is the main parameter of the
classification. First, the subword complexity function54 of pneumococcus was
calculated using JellyFish55 (v.2.2.10) (Extended Data Fig. 5). Then, based on the
characteristics of the function and the k-mer range supported by ProPhyle, the
possible range of k was determined as previously described17,32. For these k-mer
lengths, RASE indexes were constructed and their performance evaluated using
the RASE prediction pipeline and selected experiments. While RASE showed
robustness to k-mer length in terms of final predictions, prediction delays differed
(Extended Data Fig. 6). Based on the obtained timing data, we set the k-mer length
to k = 18.
Comparison to Kraken. For each RASE database, a fake NCBI taxonomy was
generated from the database tree. Then, a library was built using Kraken31 (v.1.1.1,
default parameters) from the same FASTA files as used for building the RASE
database. Finally, Kraken databases were constructed for both k = 18 and k = 31.
The obtained Kraken databases were used to classify reads from individual
experiments. The obtained Kraken assignments were subsequently converted using
an ad hoc Python script to RASE-BAM (a subset of the BAM format53 used by
RASE). Finally, RASE prediction was applied on the BAM files, with the use of the
RASE database metadata, and the results compared with the results of the standard
RASE with ProPhyle.
Measuring time. To determine how RASE works with nanopore data generated
in real time, the timestamps of individual reads were extracted using regular
expressions from the read names. These were then used for sorting the base-called
nanopore reads by time. When the RASE pipeline was applied, the timestamps
were used for expressing the predictions as a function of time. The times of
ProPhyle assignments were also compared to the original timestamps to ensure
that the prediction pipeline was not slower than sequencing.
When timestamps of sequencing reads were not available (that is, the
gonococcal WHO data and clinical samples), RASE estimated the progress in
time from the number of processed base pairs. This was done by dividing the
cumulative base-pair count by the typical nanopore flow, which we had previously
estimated from SP01 as 1.43 Mbps per s. However, such an estimated progress
is indicative only, as it does not follow the true order of reads in the course of
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sequencing. As the nanopore signal quality tends to decrease over time (see the
decrease of KS in Fig. 2 after t = 15 mins), the randomized read order provides
results of lower quality than true real-time sequencing.
Lower time estimates on resistance gene detection. A complete genome of the
multidrug-resistant SP02 isolate was assembled from the nanopore reads using
CANU56 (v.1.5, default parameters). Before the assembly step, reads were filtered
using SAMsift57 based on the matching quality with the pneumococcal RASE
database: only reads at least 1,000-bp long with at least 10% 18-mers shared with
some of the reference draft assemblies were used. The obtained assembly was
further corrected using Pilon58 (v.1.2, default parameters) and Illumina reads from
the same isolate (taxid 1QJAP in the SPARC dataset24) mapped to the nanopore
assembly using BWA-MEM59 (v.0.7.17, default parameters) and sorted using
SAMtools53.
The obtained assembly was searched for resistance-causing genes using the
online CARD tool16 (as of 1 Aug 2018). All of the original nanopore reads were
then mapped using Minimap2 (v.2.11, with ‘-x map-ont’)60 to the corrected
assembly, and resistance genes in the reads were identified using BEDtools–
intersect61 (v.2.27.1, with ‘-F 95’). Timestamps of the resistance-informative reads
were extracted and associated with the genes. Only reads longer than 2 kbp were
used in the analysis.
Evaluation of the N. gonorrhoeae WHO samples. To evaluate the predictions
of the WHO samples, we inferred a phylogenetic tree from a dataset comprising
both the GISP isolates and the WHO isolates. First, reads were downloaded for
the GISP isolates (NCBI BioProject no.: PRJEB2999 and PRJEB7904) and for the
WHO isolates F–P (NCBI BioProject no.: PRJEB4024). For the WHO isolates
U–Z, read data were simulated from the finished de novo assemblies (NCBI
BioProject no.: PRJEB14020) using Art-Illumina62 (v.2.5.1). Reads were mapped
to the NCCP11945 reference genome (GenBank accession no.: CP001050.1) using
BWA-MEM59 (v.0.7.17) and deduplicated using Picard63 (v.2.8.0). Pilon58 (v.1.16,
with ‘–mindepth 10–minmq 20’) was used to call variants and further filtered
to include only ‘pass’ sites, and sites where the alternative allele was supported
with AF > 0.9. Gubbins64 (v.2.3.4) with RAxML65 (v.8.2.10) were run on the
aligned pseudogenomes to generate the final recombination-corrected phylogeny
(Supplementary Data 1).
The closest relatives identified by RASE were verified using the obtained tree.
For every WHO isolate, the obtained RASE prediction was compared to the closest
GISP isolate on the tree.
Library preparation. For isolates SP01–SP06, cultures were grown in Todd–Hewitt
medium with 0.5% yeast extract (THY; Becton Dickinson) at 37 °C in 5% CO2 for
24 h. High-molecular-weight (>1 μg) genomic DNA was extracted and purified
from cultures using a DNeasy Blood and Tissue kit (Qiagen). DNA concentration
was measured using a Qubit fluorometer (Invitrogen). Library preparation was
performed using an ONT 1D ligation sequencing kit (SQK LSK108).
For isolates SP07–SP12, library preparation was performed using an ONT
Rapid Low-Input Barcoding kit (SQK-RLB001), with saponin-based host DNA
depletion used for reducing the proportion of human reads. More details can be
found in the original manuscript40.
For isolates GC01–GC05, cultures were grown on Chocolate-Agar media (that
is, Difco GC base media containing 1% IsoVitaleX (Becton Dickinson) and 1%
Remel Hemoglobin (Thermo Fisher Scientific)) at 37 °C in 5% CO2 for 20 h. For
GC01–GC04, genomic DNA was extracted and purified from cultures using a
PureLink Genomic DNA mini kit (Thermo Fisher Scientific). For GC05, DNA was
extracted using the phenol–chloroform method66. Genomic DNA was extracted
and purified from cultures using the PureLink Genomic DNA mini kit (Thermo
Fisher Scientific). DNA concentration was measured using a Qubit fluorometer
(Invitrogen). Library preparation was performed using the ONT 1D ligation
sequencing kit (SQK-LSK109).
MinION sequencing. Sequencing was performed on a MinION MK1 device
using R9.4/FLO-MIN106 flow cells according to the manufacturer’s instructions.
For experiments SP01–SP06, base calling was performed using ONT Metrichor
(v.1.6.11 (SP01), v.1.7.3 (SP02), v.1.7.14 (SP03–SP06)) simultaneously with
sequencing, and all reads passing Metrichor quality check were used in the further
analysis. For experiments SP07–SP12, the ONT MinKNOW software (v.1.4-1.13.1)
was used to collect raw sequencing data, and ONT Albacore (v.1.2.2-2.1.10) was
used for local base-calling of the raw data after sequencing runs were completed.
For experiments GC01–GC05, ONT MinKNOW software was used to collect raw
sequencing data, and ONT Albacore (v.2.3.4) was used for local base-calling.
Testing resistance phenotype. Additional retesting of SPARC isolates was done
using microdilution. Organism suspensions were prepared from overnight growths
on blood agar plates to the density of a 0.5 McFarland standard. This organism
suspension was then diluted to provide a final inoculum of 105 to 106 colonyforming units per ml. Microdilution trays were prepared according to the NCCLS
methodology with cation-adjusted Mueller–Hinton broth (Sigma-Aldrich)
supplemented with 5% lysed horse blood (Hemostat Laboratories)67,68. Penicillin

Nature Microbiology | VOL 5 | March 2020 | 455–464 | www.nature.com/naturemicrobiology

Articles

Nature Microbiology
(TRC Canada) and chloramphenicol (USB) concentrations ranged from 0.016
to 16 μg ml–1. Erythromycin (Enzo Life Sciences), tetracycline (Sigma-Aldrich)
and trimethoprim–sulfamethoxazole (MP Biomedicals) concentrations ranged
from 0.0625 to 64 μg ml–1. Ceftriaxone (Sigma-Aldrich) concentrations ranged
from 0.007 to 8 μg ml–1. The microdilution trays were incubated in ambient air at
35 °C for 24 h. The MICs were then visually read and breakpoints applied. A list of
individual microdilution measurements and the obtained resistance categories is
provided in Supplementary Table 2.
Resistance of streptococcus in the metagenomic samples (SP07–SP12) was
determined by agar diffusion using the EUCAST methodology and breakpoints33.
First, the inoculated agar plates were incubated at 37 °C overnight and then
examined for growth, with the potential for reincubation up to 48 h. Then, the
samples were screened to oxacillin: if the zone diameter r was >20 mm, the
isolate was considered to be sensitive to benzylpenicillin, otherwise a full MIC
measurement to benzylpenicillin was done. Finally, the isolate was screened for
resistance to tetracycline (r ≥ 25 mm for sensitive, r < 22 mm for resistant) and
erythromycin (r ≥ 22 mm for sensitive, r < 19 mm for resistant); when the isolate
showed intermediate resistance, a full MIC measurement was done.
Results for all tested samples, isolates and metagenomes are summarized in
Supplementary Table 3.
Reporting Summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.

Data availability

The analyses in the paper were performed using the following RASE databases:
“N. gonorrhoeae GISP USA v1.4” (available at https://github.com/c2-d2/rase-dbngonorrhoeae-gisp/releases) and “S. pneumoniae SPARC USA v1.3” (available
at https://github.com/c2-d2/rase-db-spneumoniae-sparc/releases). Nanopore
reads for all experiments from this study have been deposited in Zenodo with
the accession code 10.5281/zenodo.3346055; for the metagenomic experiments
(SP07–SP12), only the filtered datasets were made publicly available (that is, after
removing the remaining human reads in silico to comply with privacy policies).
Additional supplementary materials are available at https://github.com/c2-d2/rasesupplement.

Code availability

RASE was developed using Python, GNU Make, GNU Parallel69, Snakemake70
and the ETE 3 (ref. 71) and PySam53 libraries, and was based on ProPhyle27,28
(commit b55e026). Bioconda72 was used to ensure reproducibility of the
software environments. The core RASE package and RASE documentation are
available at https://github.com/c2-d2/rase. The prediction pipeline is available at
https://github.com/c2-d2/rase-pipeline. Codes for constructing the S. pneumoniae
and N. gonorrhoeae RASE databases are available at https://github.com/c2-d2/rasedb-spneumoniae-sparc and https://github.com/c2-d2/rase-db-ngonorrhoeae-gisp,
respectively. A skeleton for creating new databases is available from https://github.
com/c2-d2/rase-db-skeleton.
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Extended Data Fig. 1 | Size and memory footprint of the S. pneumoniae and N. gonorrhoeae RASE databases. The graph compares the size of the ProPhyle
RASE index to the size of the original sequences: original draft assemblies (seq−fa), original draft assemblies compressed using gzip (seq−fagz), memory
footprint of ProPhyle with the RASE index (ind−mem), and size of the ProPhyle RASE index compressed for transmission (ind−transm).
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Extended Data Fig. 2 | Timeline of resistance genes. Number of occurrences of individual resistance genes in reads of SP02, as a function of time for the
first hour of nanopore sequencing.
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Extended Data Fig. 3 | Ancestral state reconstruction of resistance categories in the S. pneumoniae RASE database. Each panel corresponds to a single
antibiotic and displays the database phylogenetic tree, colored according to the reconstructed resistance categories for the antibiotic (blue, green, red,
violet correspond to ‘susceptible’, ‘unknown – inferred susceptible’, ‘non-susceptible’, ‘unknown – inferred non-susceptible’, respectively).
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Extended Data Fig. 4 | Ancestral state reconstruction of resistance categories in the N. gonorrhoeae RASE database. Each panel corresponds to a single
antibiotic and displays the database phylogenetic tree, colored according to the reconstructed resistance categories for the antibiotic (blue, green, red,
violet correspond to ‘susceptible’, ‘unknown – inferred susceptible’, ‘non-susceptible’, ‘unknown – inferred non-susceptible’, respectively).
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Extended Data Fig. 5 | Subword complexity of pneumococcus. The plot depicts the number of canonical k-mers as a function of k for S. pneumoniae ATCC
700669 (GenBank accession: ‘NC_011900.1’) and for a random DNA text containing all possible k-mers. For k<10, the pneumococcus k-mer composition
is similar to the one of random text. For k>14, the k-mer sets are almost saturated and the complexity grows very slowly. Since the genome length is finite
and bacterial chromosomes are circular, the function attains its maximum at the genome size (2,221,315 in this case). The highlighted region corresponds
to the range of values of k, which are suitable for use in RASE.
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Extended Data Fig. 6 | Delays in prediction based on the k-mer length. The plot displays delays in prediction as a function of the used k-mer length, for
selected experiments and all possible k-mer lengths. Each horizontal panel displays times required for stabilization of one of the three predictions: the
lineage, the alternative lineage, and the closest strain. Every column within a panel corresponds to a single k-mer length. When the required time exceeded
1 hour, the point is displayed at the top. Experiments where lineage could not be identified are plotted in red. The highlighted column corresponds to the
k-mer length used for constructing the RASE databases in this paper.
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